Chief Business Officer and GC · Minerva Neurosciences, Inc. · Minerva Neurosciences, Inc. — Employee Stock Option (right to buy)
Side
A
Value
—
Shares
350.8K
Price
—
Executed
Apr 21, 2026
Disclosed
Apr 22, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Apr 21 executedApr 22, 2026 disclosed
NERV · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Minerva Neurosciences, Inc. — Employee Stock Option (right to buy)
Ticker
NERV
Shares
350.8K
Price per share
$0
Execution date (reported)
Apr 21, 2026
Owned after transaction
350.8K shares
Days from execution to publication
1
What this establishes
O'Connor James Joseph filed this Form 4 reporting a grant or award of NERV on Apr 21, 2026. It became public on Apr 22, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Business Officer and GC
O'Connor James Josephcik:0002129698
Issuer
Minerva Neurosciences, Inc.cik:0001598646
Revision history · 0
No field has changed since this record was first ingested.
